You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wilms Tumor 1

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wilms Tumor Trial in Memphis (device, drug, procedure)

Recruiting
  • Wilms Tumor
  • Proton Beam Radiation (PBRT)
  • +4 more
  • Memphis, Tennessee
    St.Jude Children's Research Hospital
Sep 1, 2021

Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q, Stage IV Wilms Tumor Trial in Worldwide (drug,

Active, not recruiting
Has Results
  • Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q
  • Stage IV Wilms Tumor
  • doxorubicin hydrochloride
  • +6 more
  • Birmingham, Alabama
  • +206 more
Mar 23, 2022

Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

Completed
  • Ewing Sarcoma
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 14, 2020

Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)

Not yet recruiting
  • Liver Cancer
  • +5 more
  • CARE T cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Dec 1, 2021

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor Trial in Worldwide (procedure, drug, biological, radiation)

Active, not recruiting
Has Results
  • Stage I Wilms Tumor
  • +2 more
  • therapeutic conventional surgery
  • +4 more
  • Birmingham, Alabama
  • +220 more
Jan 4, 2022

Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)

Unknown status
  • Wilms Tumor
  • +2 more
  • P53, Ki67 and Cyclin A IHC.
  • Mansoura, Dakahlia, Egypt
    Mansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

Recruiting
  • Glioma
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 22, 2021

Acute Myeloid Leukemia Trial in Belgium (DC vaccine)

Recruiting
  • Acute Myeloid Leukemia
  • DC vaccine
  • Antwerp, Belgium
  • +7 more
Jan 15, 2021

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Psychosocial Situation of Rare Solid Abdominal Tumors and Their

Recruiting
  • Neuroblastoma
  • +2 more
    • Mannheim, Baden-Württemberg, Germany
    • +1 more
    Feb 20, 2022

    Study of Kidney Tumors in Younger Patients

    Recruiting
    • Adult Cystic Nephroma
    • +24 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +247 more
    Sep 2, 2022

    DICER1-related Pleuropulmonary Blastoma Cancer Predisposition

    Recruiting
    • Pleuropulmonary Blastoma
    • +4 more
      • Bethesda, Maryland
      • +1 more
      Dec 29, 2022

      Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

      Not yet recruiting
      • Digestive System Neuroendocrine Tumor G1
      • +5 more
      • Tumor Debulking
      • +5 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Aug 23, 2023

      Cardiac Functions in Type 1 Diabetes Mellitus

      Not yet recruiting
      • Diabetes Mellitus, Type 1
      • +2 more
      • transthoracic echocardiography
      • (no location specified)
      Nov 12, 2023

      Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)

      Not yet recruiting
      • Stage IIIA Hepatocellular Carcinoma
      • Radiotherapy combined with TKI and Anti-PD-1 Antibody
      • (no location specified)
      Sep 24, 2023

      1 asPotential Biomarker for Colorectal Cancer Diagnosis and

      Not yet recruiting
      • Colorectal Cancer
      • Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
      • (no location specified)
      Mar 20, 2023

      Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

      Recruiting
      • Atypical Teratoid Rhabdoid Tumor
      • +6 more
      • Boston, Massachusetts
      • +1 more
      Jan 23, 2023

      NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

      Not yet recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Tumor treating fields（EFE-P100）
      • Docetaxel injection
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Dec 21, 2022

      Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +31 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +118 more
      Jan 27, 2023

      Advanced Solid Tumor Trial in Brussels (GTAEXS617)

      Recruiting
      • Advanced Solid Tumor
      • Brussels, Belgium
        Clinique Universitaires Saint-Luc
      Aug 8, 2023

      Advanced Solid Tumor Trial (HBM1020)

      Not yet recruiting
      • Advanced Solid Tumor
      • (no location specified)
      Apr 10, 2023

      Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)

      Not yet recruiting
      • Advanced Solid Tumor
      • Oncolytic Virus Injection（Revottack）+PD-1
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Dec 1, 2022

      Gut and Tumor Microbiome in Advanced ER-positive and

      Not yet recruiting
      • Breast Cancer
      • Melanoma
      • Observation
      • (no location specified)
      Nov 6, 2023

      Metastasis, Solid Tumor Trial (Peptide Alarm Therapy (PAT))

      Not yet recruiting
      • Metastasis
      • Solid Tumor
      • Peptide Alarm Therapy (PAT)
      • (no location specified)
      Nov 2, 2022